Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies

Gain in-depth knowledge on new and emerging therapies for hereditary angioneurotic edema (HAE), including long-term prophylactics, to help patients achieve disease control and improved quality of life by attending a live satellite symposium and reviewing the accompanying downloadable slides and expert-written ClinicalThought commentaries.

Share

Program Content

Activities

Prophylaxis of HAE
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2024

Expires: May 30, 2025

Activities

Hereditary Angioedema
Addressing Challenges in Long-Term Prophylaxis for Hereditary Angioedema
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2024

Expires: June 26, 2025

LTP for HAE
Patient-Centered Long-Term Prophylaxis Strategies for Hereditary Angioedema
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2024

Expires: June 26, 2025

Faculty

cover img faculity

Jonathan A. Bernstein, MD

Adjunct Professor of Medicine
Department of Internal Medicine
Division of Rheumatology, Allergy and Immunology
Director of the University of Cincinnati Allergy and Research Laboratory and Allergy Clinical Trials
Partner of Advanced Allergy Services
Partner of Bernstein Clinical Research Center
Cincinnati, Ohio

cover img faculity

Marc Riedl, MD, MS

Professor of Medicine
HAE Community Endowed Chair
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief, Division of Allergy & Immunology
University of California, San Diego
San Diego, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.